Filtered By:
Specialty: Universities & Medical Training
Nutrition: Vitamin A

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1635 results found since Jan 2013.

Effects of Progesterone and Other Gonadal Hormones on Glutamatergic Circuits in the Retina
CONCLUSIONS: Progesterone, but not estrogen or testosterone, activated glutamate release in the mouse retina. Increases in the concentration of progesterone during pregnancy did not induce any detectable change in retinal thickness.PMID:37690823 | DOI:10.1272/jnms.JNMS.2023_90-405
Source: Journal of Nippon Medical School - September 10, 2023 Category: Universities & Medical Training Authors: Mahito Ohkuma Takuma Maruyama Toshiyuki Ishii Nozomi Igarashi Keiko Azuma Tatsuya Inoue Ryo Obata Ei-Ichi Miyachi Makoto Kaneda Source Type: research

Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research

Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | PMC:PMC10386106 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research

Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research

Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research

Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334.ABSTRACTIn this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant and anti-inflammatory properties that may support conventional therapies will be considered, with the final aim of achieving risk reduction (prevention) and outcome improvement (cooperation between treatments) of such sight-threatening proliferative retinopathies. For this purpose, we consider a medicinal product one that contains well-defined compoun...
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Dario Rusciano Paola Bagnoli Source Type: research

Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.PMID:37512134 | PMC:PMC10386106 | DOI:10.3390/medicina59071324
Source: Medicina (Kaunas) - July 29, 2023 Category: Universities & Medical Training Authors: Kati K ärberg Alastair Forbes Margus Lember Source Type: research